Development of a novel multi-layer microfluidic device towards characterization of drug metabolism and cytotoxicity for drug screening.
A novel multi-layer microfluidic device was developed for characterization of drug metabolism in human liver microsomes (HLMs) and their cytotoxicity on cells. The results demonstrated that this platform is robust for low levels of compounds and shows potential for high-throughput drug screening in drug development.